A股異動 | 立昂技術(300603.SZ)再次漲停破頂 受疫情影響互聯網流量紅利釋放
格隆匯2月18日丨立昂技術(300603.SZ)今日再次漲停續創新高,現報40.78元,暫成交2.69億元,最新總市值114.61億元。公司股價近期走勢極為強勢,從一月初以來累計飆升超125%。近兩日又走出連續漲停,股價不斷破頂。

針對本次新冠疫情,公司通過互聯網平台、電視IPTV端等開設疫情防控新聞專區。此外,公司結合自身CDN加速和雲安全技術能力,7*24小時不間斷提供網絡加速服務,確保網絡服務質量;同時,助力雲課堂、雲醫療、雲辦公的開展。
受此次疫情影響,流量紅利的釋放使得公司一月份在電子書售賣方面創收達4200萬元,同比增長近30%,二月份僅5天便有近800萬元的收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.